Medicare Part D's coverage gap may be gone, but prescription drug costs remain an important concern for retirees.
Recent changes have strengthened the benefit and introduced a cap on annual out-of-pocket spending.
Still, those updates don't eliminate the need for planning. Instead, they change how costs are experienced.
Rather than facing a mid-year spike, beneficiaries are more likely to see expenses concentrated earlier in the year, making it essential for their advisors to understand how those costs unfold and how those costs fit within a monthly budget.
The Question: If the Medicare Part D "donut hole" has been eliminated, do retirees still need to worry about high prescription drug costs?
The Answer: The elimination of the Medicare Part D coverage gap, commonly known as the donut hole, marks a meaningful change in how beneficiaries experience prescription drug costs.
However, it doesn't remove the need for planning. Instead, it shifts the focus: Retirees now need to pay closer attention to when costs occur and how they're paid throughout the year.
This distinction matters for both advisors and beneficiaries.
Like other recent Medicare updates, these changes are designed to improve affordability and access.
But understanding how they work in practice is key to making informed decisions.
Understanding the New Part D Structure
This year, Medicare Part D no longer includes a coverage gap phase.
Instead, the benefit is divided into three main stages:
◆ Deductible phase: Beneficiaries pay 100% of drug costs until they meet the annual deductible.
◆ Initial coverage phase: Costs are shared based on the plan's design, typically through copayments or coinsurance.
◆ Catastrophic phase: After beneficiaries reach the annual out-of-pocket maximum, they pay no cost sharing for covered Part D drugs for the rest of the year.
In 2026, the out-of-pocket maximum is about $2,100, with a deductible that may reach up to $615. This cap offers meaningful financial protection.
However, the cap doesn't eliminate the possibility of higher costs early in the year.
This reflects a broader trend in Medicare policy.
The program is reducing long-term financial risk while still requiring some upfront cost sharing.
The Shift From Coverage Gaps to Cash Flow Planning
In the past, the donut hole often caused a sudden increase in drug costs halfway through the year. Its elimination removes that disruption.
But the elimination of the donut hole introduces a different challenge: how costs are spread over time.
Beneficiaries may now experience:
◆ Higher out-of-pocket spending early in the year, especially for high-cost medications.
◆ Ongoing, monthly cost changes, depending on prescription use.
◆ A greater need to plan for predictable but front-loaded expenses.
This shift mirrors other Medicare changes aimed at improving consistency in coverage.
While the system is becoming more predictable, it still requires beneficiaries to manage how and when they pay for care.
Medicare Prescription Payment Plan
To help manage out-of-pocket prescription drug costs, Medicare introduced the Medicare Prescription Payment Plan, or M3P.
This voluntary program is available to all Medicare Part D enrollees.
Key features include:
◆ Cost-smoothing: Beneficiaries can spread their out-of-pocket prescription costs through monthly payments, rather than paying the full amount when filling prescriptions.
◆ No cost reduction: The program doesn't lower total drug costs; it only changes when those costs are paid.
Total out-of-pocket spending remains the same under the plan design.
◆ Availability: All Medicare Part D plans are required to offer the Medicare Prescription Payment Plan.
◆ Participation: Beneficiaries can choose whether to opt in.
Beneficiaries who don't participate continue to pay cost-sharing at the pharmacy when prescriptions are filled.
This program is designed to help Medicare beneficiaries manage their monthly expenses more easily, especially if they face high costs early in the year.
Why This Matters for Advisors
Advisors should be ready to discuss:
◆ Timing of expenses: Out-of-pocket drug costs may be concentrated at different points in the year, depending on medication use and plan design.
◆ Income alignment: This involves assessing whether monthly income can support periods of higher drug spending, whether early or later in the year.
◆ Payment plan participation: Advisors may evaluate whether the Medicare Prescription Payment Plan supports a client's budgeting needs, noting that it spreads costs over time but doesn't reduce total spending.
◆ Medication review: As part of annual Medicare planning, clients can review prescriptions that may significantly affect overall drug spending.
The Takeaway
The elimination of the Medicare Part D donut hole is a meaningful development.
It reduces the risk of sudden cost increases and places a clear limit on annual out-of-pocket spending.
However, even improvements in Medicare can introduce new planning considerations.
Tricia Blazier is director of Healthcare Insurance Services at Allsup.
© Arc, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to TMSalesOperations@arc-network.com. For more information visit Asset & Logo Licensing.